Accelerating Medicines Partnership (AMP)
Accelerating Medicines Partnership (AMP) is a new venture that brings together the Foundation for the National Institutes of Health (FNIH), the National Institute of Health (NIH), 10 bio pharmaceutical companies and several non-profit organizations to work toward a common goal of earlier drug discovery and development for diseases, including rheumatoid arthritis and lupus. As part of this cross-sector partnership, we will be able to share expertise and resources in a way that enables the best informed contributions to science. One critical component of this partnership is that industry partners will make the data and analysis resulting from AMP available to the broader bio-medical community. Learn More.
The Biomarkers Consortium
The Biomarkers Consortium is a public-private biomedical research partnership managed by the Foundation for the National Institutes of Health that endeavors to discover, develop, and seek regulatory approval for biological markers (biomarkers) to support new drug development, preventive medicine, and medical diagnostics. The consortium is helping create a new era of personalized medicine, with more highly predictive markers that have an impact during a patient’s illness or lifespan. Our goal is to combine the forces of the public and private sectors to accelerate the development of biomarker-based technologies, medicines, and therapies for the prevention, early detection, diagnosis, and treatment of disease. Learn More.
The Childhood Arthritis and Rheumatology Research Alliance (CARRA)
The Arthritis Foundation has supported CARRA from the start, providing funding for its development and ongoing funding for its administrative core and support for the CARRA registry. CARRA has created consensus treatment plans to improve and standardize care of pediatric rheumatic diseases. Learn More.
Healthy People 2020
Healthy People provides science-based, 10-year national objectives for improving the health of all Americans. For 3 decades, Healthy People has established benchmarks and monitored progress over time in order to: Encourage collaborations across communities and sectors, empower individuals toward making informed health decisions, and measure the impact of prevention activities. Learn More.